Is Vitamin K Shot Necessary For Newborns

🖨️ Print post

Play Audio

The discovery of a pregnancy is often met with quiet, sacred joy. To confirm the new life taking shape, many women make their way to their doctor’s office, where the pregnancy is medically recognized. But with that first ap­pointment, something else begins—entry into a standardized system that has mapped out nearly every step of prenatal care in advance.

From that moment on, a series of scheduled visits unfolds, involving checkups, ultrasounds, blood tests, screenings and diagnostic tests for conditions like Down syndrome. Medical personnel also encourage expectant mothers to receive multiple vaccinations: the flu shot, the combination tetanus-diphtheria-pertussis (Tdap) vaccine and, more recently, the respira­tory syncytial virus (RSV) and Covid injections. Each recommendation is framed as offering protection and reassurance, and—trusting the system—most women follow along.

When labor begins, many parents giv­ing birth in a hospital setting arrive without a comprehensive birth plan or full awareness of what will be done to their newborn in those first tender hours. Hospitals, for their part, operate by protocol—a checklist that begins the moment a baby draws his or her first breath.

One of the first items on that list is the vita­min K injection, typically given without ques­tion, without pause, and often without parents’ full understanding of its purpose or ingredients. Though not technically a vaccine, vitamin K shots are part of a suite of Day One hospital interventions¹ that also include the hepatitis B vaccine, RSV monoclonal antibody prophylaxis (recommended by the CDC for infants born during the RSV “season” if the mother did not get the vaccine fourteen days prior to delivery), antibiotic eye ointment and newborn metabolic screenings.²

Let’s take a closer look at the vitamin K shots—not out of fear but from a place of rev­erence for new life and deep respect for the responsibility of informed consent.

Vitamin K is an essential nutrient that plays a critical role in the body’s ability to form blood clots. The name “vitamin K” comes from the German word Koagulation, highlighting its importance in the clot­ting process.

Because our bodies cannot produce vitamin K and can store it only in small amounts, we must rely on dietary sources to meet our needs. The two primary forms are vitamin K1 (phylloquinone), a water-soluble, plant-based form found in leafy green vegetables, and fat-soluble vitamin K2 (menaquinones), found in animal-based and fermented foods and pro­duced by beneficial gut bacteria.^3,4 Both forms of vitamin K are vital for activating proteins involved in blood coagulation and other physiological functions, but they differ in their absorption rates, tissue distribution and bioavailability.⁵

Vitamin K2—or “Activator X” as Dr. Weston A. Price called it—is more involved in long-term health. It supports reproductive health, plays a key role in prevention of tooth decay, builds strong, resilient bones and helps protect blood vessels by discouraging calcium buildup and reducing inflammation. The highest concentration of vitamin K2 is in the brain, where it supports the formation of the myelin sheath—crucial for learning and cognitive function; it also helps produce lipids (called sulfatides) that are vital for brain health and whose absence may be linked to neurologi­cal issues such as seizures.

In children, vitamin K2 contributes to healthy growth by ensuring that the bone growth plates stay open long enough to allow proper de­velopment, particularly of the face. It is essential not only for skeletal and neurological development but also for overall energy metabolism.⁶

Hospitals began routinely giving newborns a single shot of phytona­dione, a synthetic form of vitamin K1, in 1961.⁷ The stated rationale for administering the injection is to prevent vitamin K deficiency bleeding (VKDB), a rare but serious condition, involving insufficient clotting factors, that can arise with little warning. VKDB places infants at risk of spontaneous bleeding anywhere in the body, including the brain (in­tracranial hemorrhage).⁸

There are three types of VKDB, classified according to the timing of onset. “Early VKDB,” occurring within the first twenty-four hours of a baby’s life, is most often associated with maternal medications like the anticoagulant warfarin⁹ (see the article on anticoagulants in this issue of Wise Traditions), which interferes with vitamin K metabolism. “Classical VKDB” (between days two and seven) typically presents as bleeding from the umbilical stump or gastrointestinal tract. “Late VKDB” (between weeks two and twelve) is the rarest but most dangerous form, frequently involving life-threatening intracranial bleeding.⁷ Symptoms of VKDB can include bulging fonta­nelles, bruising, feeding intolerance, irritability, nosebleeds, jaundice and pallor.

The CDC says that newborns enter the world with naturally low levels of vitamin K, blaming biological factors such as limited pla­cental transfer of vitamin K, immature gut flora and minimal levels present in breast milk.¹⁰ But are these naturally low levels truly a pathologi­cal deficiency or simply a normal part of neona­tal physiology? As many researchers and parents opposed to the injections argue, if all newborns are born with what we define as “low” vitamin K levels—with “deficiency” determined on the basis of adult norms—perhaps those “low” levels are biologically appropriate for this early stage of life and not pathological. Moreover, critics contend, administering vitamin K in­jections without a deeper understanding of the long-term consequences amounts to overriding nature’s design.

Newborn vitamin K shots illustrate how interventions aimed at addressing presumed “deficiencies” can introduce new challenges— raising important questions about the balance between prevention and adverse effects.¹¹ The injections may be intended to prevent one seri­ous condition, but ironically, the large dose of synthetic K1—one hundred times greater than the Recommended Daily Allowance for infants6—can trigger complications such as jaundice, impairing the infant liver and its abil­ity to detoxify.

The CDC warns parents who question the vitamin K shots that babies who do not receive them are eighty-one times more likely to de­velop late VKDB,10 but the absolute risk is low. Again according to CDC, somewhere between one in fourteen thousand and one in twenty-five thousand infants who are not given the vitamin K shot will develop late VKDB.¹⁰

The website Giving Birth Naturally points out that a number of factors associated with hospital births can increase the risk of cerebral hemor­rhage; these include precipitous or prolonged labor, significant fetal head molding, birth trauma, forceps or vacuum-assisted delivery, variable heart rate decelerations during late labor and circumcision.¹¹ The immediate clamping and cutting of the umbilical cord also deprives babies of up to 30 percent of their blood,¹² including clotting factors.

Contrary to what many parents probably believe, vitamin K injections contain more than just a “vitamin.” In addition to synthetic compounds, chemical stabilizers and preservatives (see sidebar), they sometimes contain aluminum—a known neurotoxin (see next section). Package inserts for aluminum-containing vitamin K products caution that the aluminum “may be toxic,”¹³ notably for premature infants whose systems are especially vulnerable.

Immediate adverse reactions to synthetic vitamin K have included respiratory distress, skin rashes, swelling and anaphylaxis. In premature neonates and infants in intensive care, the preservative benzyl alcohol has been linked to “gasping syndrome” and fatal reactions.^13,14 The manu­facturer of one phytonadione product—a Pfizer subsidiary—provides labeling that is strikingly clear: “Severe reactions, including fatalities, have occurred during and immediately after intravenous injection of phytonadione.”^13,14 The insert continues, “Severe reactions, including fatalities, have also been reported following intramuscular administra­tion.”^13,14 This is not conjecture—it is printed in black and white.

Beyond acute events, there are broader concerns about the safety profile of synthetic vitamin K—even at standard doses. Other documented side effects include cytotoxicity in liver cells, formation of free radicals and mutagenic effects,¹⁵ all of which are suggestive of potential long-term toxicity. Synthetic vitamin K also weakens the immune system, interferes with the body’s natural vitamin K cycle and disturbs calcium metabolism. In addition to hyperbilirubinemia (jaundice), it can produce effects like vomiting, hemolytic anemia (the abnormal breakdown of red blood cells), albuminuria (a sign of kidney problems), irritation of the skin and mucous membranes, eczema and other allergic reactions.^15-17

In the 1990s, a few researchers expressed concern about potential carcinogenic effects of intramuscular vitamin K shots, describing a pos­sible link with childhood leukemia^18,19 and other childhood cancers.^20,21 Other researchers promptly refuted the claims,²² as did health officials, effectively squashing any further investigation of the topic. For the authors of the 1992 paper, who found the relationship between intramuscular vitamin K and childhood cancer “biologically plausible,” the conclusion was that the benefits of the newborn shots were “unlikely to exceed the potential adverse effects.”²⁰

Aluminum is one of the most controversial ingredients in early-life medical interventions. Dr. Christopher Exley, a leading authority on alu­minum toxicity, has published a large body of research in peer-reviewed journals showing that aluminum can accumulate in brain tissue and may remain there for decades.²³ Exley’s work has raised concerns about the cumulative and biologically persistent impact of aluminum from multiple sources that include vaccines, intravenous formulas,²⁴ environmental exposures and some vitamin K shots.

For newborns, hepatitis B vaccines are a Day One aluminum ex­posure. Like the vitamin K shots, hepatitis B vaccination is a universal recommendation for U.S. babies, despite the fact that few are at risk. One dose contains two hundred fifty micrograms of aluminum—an amount that far exceeds Agency for Toxic Substances and Disease Registry (ATSDR) safety thresholds when adjusted for an infant’s body weight. In fact, this is approximately seventy-five times higher than what is consid­ered “safe” for a 7.3-pound newborn in a single day.²⁵ By two months of age, the standard vaccination schedule can expose an infant to as much as one thousand two hundred twenty-five micrograms of aluminum—and nearly five thousand micrograms by eighteen months.²⁶

Because the detoxification pathways of babies in utero and in the early days of life are immature, their developing brains are highly sus­ceptible to disruption.²⁷ Introducing even small amounts of neurotoxic compounds during this delicate window of development could have lasting consequences.

Research shows that aluminum has the potential to damage brain cells essential for thinking, memory and movement. Introduced into the body in the form of vaccine adjuvants, aluminum can overstimulate the immune system, sometimes leading to harmful inflam­matory or autoimmune responses.²⁸ A growing body of evidence links aluminum adjuvants to an increased risk of conditions such as chronic fatigue, cognitive impairment, muscle weak­ness and multiple-sclerosis-like disorders, as well as arthritis, type 1 diabetes, lupus and inflammatory bowel disease.²⁹ Aluminum is also associated with the neurological changes seen in autism spectrum disorders, which now affect a staggering one in thirty-one children in the U.S. The growing prevalence of autism should be prompting serious questions about environmental and pharmaceutical contributors such as aluminum.³⁰

Many researchers have argued that a viable alternative to injection of synthetic vitamin K is oral supplementation, an approach adopted by countries such as the Netherlands,³¹ Japan³² and Switzerland.³³ Where oral administration has been integrated into standard newborn care, rates of VKDB are remarkably low. Although not approved by the U.S. Food and Drug Ad­ministration (FDA), oral vitamin K, particularly in the form of high-quality, preservative-free drops from natural sources, offers a gentler, more integrative approach that aligns with many families’ desire for minimal intervention.

For those concerned about the efficacy of oral vitamin K supplementation, the research is encouraging. One study found that both oral and intramuscular vitamin K1 led to compa­rable rises in serum vitamin K levels within twelve hours of birth, with a similar half-life of about thirty hours.³⁴ There were no significant differences in the activity of key clotting fac­tors during the early days of life, leading the investigators to conclude that oral vitamin K1, when administered properly, “is as effective as the intramuscular route” in the immediate newborn period.

That said, it is important to recognize that there have been no randomized controlled trials specifically measuring the impact of either in­tramuscular injection or oral administration on late-onset VKDB.³⁵ This highlights the impor­tance of informed decision-making, especially given that late VKDB primarily affects a small subset of babies who may be at higher risk due to underlying conditions or childbirth-related factors.

Expectant mothers can support their baby’s vitamin K levels by regularly including foods rich in this essential nutrient during pregnancy. As already mentioned, leafy green vegetables provide excellent sources of vitamin K1, while mothers can obtain vitamin K2 from foods like cheese (especially hard cheeses),³⁶ liver, egg yolks, butter, poultry fat and meat from grass-fed animals. Incorporating lactofermented foods into the daily diet encourages the growth of beneficial bacteria in the mother’s gut and birth canal, which can aid in vitamin K production. These nutrients and microbes can be passed to the baby through the placenta before birth and through exposure during vaginal delivery.⁶

After birth, immediate and frequent breastfeeding continues this natural support. Colostrum—the golden, nutrient-rich fluid produced in the first days postpartum—contains a concentrated dose of vitamin K.¹¹ Colostrum from a well-nourished mother will deliver vital nutrients in proportions exquisitely tailored to a newborn’s early needs. It makes sense that nature designed infants to receive their first nourishment this way: directly from their mother, through the intimate act of breastfeed­ing—laying the groundwork for resilience, health and balance from the very beginning.

Vitamin K shots are not simple vitamins or benign interventions— they are pharmaceutical products that come with trade-offs, formulated with synthetic ingredients and administered at doses far exceeding what nature provides. Moreover, because a newborn’s liver doesn’t begin functioning fully until three to four days after birth, babies have very little ability to process or detoxify the high dose of synthetic vitamin K and its accompanying ingredients.⁶

Some parents who understand this choose to forego vitamin K supplementation entirely, instead placing their trust in careful maternal nutrition, exclusive and early breastfeeding and the body’s innate ability to regulate itself. While this choice carries a theoretical risk, it can be a considered an informed one.

For the small number of infants who may be at higher risk of de­ficiency-related bleeding, oral vitamin K may be a sensible precaution. Because hospitals in the U.S. are often unfamiliar with oral vitamin K protocols, families interested in this route should plan ahead. Partnering with a supportive provider who understands international best practices and appropriate dosing is key, as standard hospital staff may not be trained to offer or manage this option.

It is still worth asking whether newborns’ naturally low vitamin K levels might serve a physiological purpose—perhaps even playing a pro­tective role during birth and the early weeks of life.³⁷ Ultimately, parents should make the decision of whether and how to administer vitamin K with intention, grounding the decision in their family values, reviewing the available evidence and gaining an honest understanding of potential risks and benefits.

There is also a deeper conversation to be had about childbirth—one that acknowledges birth not only as a medical event but as a profound rite of passage. The newborn experience is sacred. Every touch, breath and intervention sends a message to the infant’s nervous system. Do we want to rush them into the world with cold hands and needles, or warmly welcome them with reverence, patience and trust?

One vital expression of that reverence is delaying the cutting of the umbilical cord. As mentioned, immediate clamping—often done to expedite newborn procedures like the vitamin K and hepatitis B injec­tions—can deprive a baby of up to 30 percent of blood volume, along with precious stem cells critical for early development. Delayed cord clamping, in contrast, supports a smoother transition into life outside the womb, enhances oxygenation, bolsters natural immunity and has been shown to reduce the risk of intraventricular hemorrhage and late-onset sepsis.³⁸ The cord blood also provides a rich source of vitamin K for the baby if the mother consumes plenty of vitamin K in her diet.⁶

Medical interventions may have their place, but they should never be automatic. They should be thoughtful, transparent and offered with full disclosure, not coercion. Informed consent is a fundamental human right, not a formality. Parents deserve to know what is being injected into their babies and why—which means understanding not just the benefits but also the rationale, risks, ingredients and alternatives. They deserve time and space to make a thoughtful, informed decision without pressure.

Let us return to a model of care that honors parents as sovereign decision-makers. The greatest gift parents can give their newborn is their presence, protection and awareness. That includes keeping the baby close at all times—either with the parents or a trusted family member—so that no intervention, whether a vitamin K shot or vaccine or anything else, is given without full knowledge and consent. Parents who eschew blind obedience and do their research, ask the deeper questions, trust their intuition and make a plan will be well equipped to engage in the most radical parenting act of all—conscious, informed love.

---

SIDEBAR

TROUBLING INGREDIENTS IN VITAMIN K SHOTS

POLYSORBATE 80: A chemical emulsifier linked to gut inflammation, immune system disruption and potential carcino­genic byproducts.^39-41

PROPYLENE GLYCOL: A synthetic solvent also used in antifreeze. Linked to metabolic issues, neurotoxicity and toxic buildup in infants with immature liver detox pathways.⁴²

BENZYL ALCOHOL: A preservative associated with “gasping syndrome” in premature infants, which can lead to meta­bolic acidosis, seizures, respiratory failure and death.⁴³

POLYETHOXYLATED FATTY ACID DERIVATIVES: Derived from castor oil, these are used as an emulsifier; may provoke allergic reactions or impact underdeveloped immune systems.⁴⁴

LECITHIN: Another emulsifier; while naturally derived, it can cause allergic reactions and affect gut permeability.⁴⁵

HYDROCHLORIC ACID: Used to adjust the pH of the injection; corrosive in nature.⁴⁶

SODIUM HYDROXIDE: Another pH adjuster; highly caustic in concentrated forms.^47,48

GLYCERIN (GLYCEROL): Added for stability. In large doses, can cause headaches, nausea and central nervous system issues, especially in neonates.⁴⁹

SODIUM CHLORIDE (SALT): Used to balance tonicity. In neonates, electrolyte imbalance can be serious and even life-threatening.⁵⁰

WATER FOR INJECTION (WFI): Sterile water. If contaminated with endotoxins, can trigger dangerous inflammatory responses.⁵¹

ETHANOL/DEHYDRATED ALCOHOL: Used as a solvent in some formulations; even trace amounts may affect liver and neurological development in newborns.⁵²

GLYCOCHOLIC ACID: A bile acid derivative used as an emulsifier in certain formulations. May cause irritation and is not typically present in natural nutrition at birth.⁵³

Even “preservative-free” formulations of the synthetic vitamin K injection contain additives such as polysorbate 80, pro­pylene glycol, sodium acetate anhydrous and glacial acetic acid (vinegar)⁵⁴ to aid in solubility and absorption.⁵⁵

---

REFERENCES

1. Teller M. Prenatal and newborn interventions—it’s an onslaught. Wise Traditions. Summer 2024;25(2):48-55.
2. McKee-Garrett TM. Overview of the routine management of the healthy newborn infant. UpToDate, updated Apr. 18, 2025.
3. Eden RE, Daley SF, Coviello JM. Vitamin K deficiency. 2023 Sep 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
4. Reddy P, Jialal I. Biochemistry, fat soluble vitamins. 2022 Sep 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
5. Halder M, Petsophonsakul P, Akbulut AC, et al. Vitamin K: double bonds beyond coagulation insights into differ­ences between vitamin K1 and K2 in health and disease. Int J Mol Sci. 2019 Feb 19;20(4):896.
6. Morell SF, Cowan TS. The Nourishing Traditions Book of Baby & Child Care. Washington, DC: New Trends Publishing, 2013, pp. 7-8, 102-103.
7. CDC. How to protect babies from life-threatening bleeding. Jan. 17, 2025. https://www.cdc.gov/vitamin-k-deficiency/hcp/fact-sheet/index.html
8. CDC. Frequently asked questions about vitamin K de­ficiency bleeding. Jan. 17, 2025. https://www.cdc.gov/ vitamin-k-deficiency/faq/index.html
9. Sagaidac I, Rotaru D, Cernetchi O. Antenatal anticoagu­lant therapy and neonatal hemorrhagic syndrome. Case report. Folia Med (Plovdiv). 2022 Dec 31;64(6):991-997.
10. CDC. About vitamin K deficiency bleeding. Jan. 17, 2025. https://www.cdc.gov/vitamin-k-deficiency/about/index.html
11. Beier C. Newborn vitamin K injections. Giving Birth Naturally, updated May 16, 2025. https://www.givingbirthnaturally.com/newborn-vitamin-k.html
12. Delayed cord clamping. American Pregnancy Asso­ciation, n.d. https://americanpregnancy.org/healthy-pregnancy/labor-and-birth/delayed-cord-clamping/
13. https://labeling.pfizer.com/ShowLabeling.aspx?id=4669
14. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/012223s040lbl.pdf
15. Stellpflug C. The deadly effects of synthetic vitamin K. Natural News, Aug. 27, 2012.
16. Council for Responsible Nutrition (CRN). Vitamin K. Excerpted from Vitamin and Mineral Safety, 3rd Edition. CRN, 2013. https://www.crnusa.org/sites/default/files/files/resources/09-CRNVMS3-VITAMINK.pdf
17. Johnson LE. Vitamin K toxicity. Merck Manual: Pro­fessional Version, revised Aug. 2024. https://www.merckmanuals.com/professional/nutritional-disorders/vitamin-deficiency-dependency-and-toxicity/vitamin-k-toxicity
18. Parker L, Cole M, Craft AW, et al. Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ. 1998 Jan 17;316(7126):189-193.
19. Passmore SJ, Draper G, Brownbill P, et al. Case-control studies of relation between childhood cancer and neonatal vitamin K administration. BMJ. 1998 Jan 17;316(7126):178-184.
20. Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ. 1992 Aug 8;305(6849):341-346.
21. Golding J, Paterson M, Kinlen LJ. Factors associated with childhood cancer in a national cohort study. Br J Cancer. 1990 Aug;62(2):304-308.
22. Klebanoff MA, Read JS, Mills JL, et al. The risk of child­hood cancer after neonatal exposure to vitamin K. N Engl J Med. 1993 Sep 23;329(13):905-908.
23. Exley C, Mold MJ. Aluminium in human brain tis­sue: how much is too much? J Biol Inorg Chem. 2019 Dec;24(8):1279-1282. Erratum in: J Biol Inorg Chem. 2019 Dec;24(8):1283.
24. Bishop NJ, Morley R, Day JP, et al. Aluminum neuro­toxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med. 1997 May 29;336(22):1557-1561.
25. Hepatitis B vaccine: is it safer than hepatitis B? Physicians for Informed Consent, Aug. 2022 (updated Aug. 2024). https://physiciansforinformedconsent.org/hepatitis-b-vrs/
26. Miller NZ. Aluminum in childhood vaccines is un­safe. Journal of American Physicians and Surgeons. 2016;21(4):109-117.
27. Shekhawat DS, Singh P, Janu VC, Sharma P, Singh K. Maternal and newborn blood aluminum levels and neu­rodevelopment of infants: is there a need for concern? Indian J Clin Biochem. 2023 Jan;38(1):136-141.
28. Tomljenovic L, Shaw CA. Aluminum vaccine adjuvants: are they safe? Curr Med Chem. 2011;18(17):2630-2637.
29. Miller NZ. Miller’s Review of Critical Vaccine Studies: 400 Important Scientific Papers Summarized for Parents and Researchers. Santa Fe, NM: New Atlantean Press, 2016, p. 44.
30. HHS Press Office. “Autism epidemic runs rampant,” new data shows 1 in 31 children afflicted. U.S. Department of Health and Human Services, Apr. 15, 2025.
31. de Winter JP, Joosten KF, Ijland MM, et al. Nieuwe Nederlandse richtlijn voor vitamine K-toediening aan voldragen pasgeborenen [New Dutch practice guideline for administration of vitamin K to full-term newborns]. Ned Tijdschr Geneeskd. 2011;155(18):A936. Dutch.
32. Koe T. Vitamin K supplementation among infants helps prevent VKDB—Japan review. NutraIngredients Asia, Apr. 9, 2020.
33. Schubiger G, Stocker C, Bänziger O, et al. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr. 1999 Jul;158(7):599-602.
34. Goldschmidt B, Kisrákói C, Téglás E, et al. K1-vitamin koncentráció és a K-vitamin dependens alvadási faktorok újszülöttekben K1-vitamin intramuscularis és oralis adása után [Vitamin K 1 concentration and vitamin K-dependent clotting factors in newborn infants after intramuscular and oral administration of vitamin K 1]. Orv Hetil. 1990 Jun 17;131(24):1297-1300. Hungarian.
35. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev. 2000;2000(4):CD002776.
36. Vermeer C, Raes J, van ʼt Hoofd C, et al. Menaquinone content of cheese. Nutrients. 2018 Apr 4;10(4):446.
37. Wickham S. Vitamin K—an alternative perspective. AIMS Journal. 2002;13(2). https://www.aims.org.uk/journal/item/vitamin-k-an-alternative-perspective
38. Mercer JS, Vohr BR, McGrath MM, et al. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics. 2006 Apr;117(4):1235-1242.
39. Polysorbate 60, 65, and 80. Center for Science in the Public Interest, updated Feb. 6, 2022. https://www.cspinet.org/article/polysorbate-60-65-and-80
40. Coors EA, Seybold H, Merk HF, et al. Polysorbate 80 in medical products and nonimmu­nologic anaphylactoid reactions. Ann Allergy Asthma Immunol. 2005 Dec;95(6):593-599.
41. What are polysorbates: chemical free living. Force of Nature, n.d. https://www.forceofna­tureclean.com/chemical-free-living-polysorbates/
42. O’Donnell J, Merti SL, Kelly WN. Propylene glycol toxicity in a pediatric patient: the dangers of diluents. Journal of Pharmacy Practice. 2000 Jun;13(3):214-225.
43. Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alco­hol—United States. MMWR Morb Mortal Wkly Rep. 1982 Jun 11;31(22):290-291.
44. Renier R, Breynaert C, Dens AC, et al. Allergic reactions to polyethoxylated castor oil derivatives: A guide to decipher confusing names on pharmaceutical labels. J Allergy Clin Immunol Pract. 2020 Mar;8(3):1136-1138.e2.
45. SIAIP Food Allergy Commission, Anania C, Cuomo B, et al. Intestinal barrier dysfunction and food allergy. Italian Journal of Pediatric Allergy and Immunology. 2024;38(2).
46. https://medlibrary.org/lib/rx/meds/vitamin-k1/page/3/
47. MedlinePlus [Internet]. Sodium hydroxide poisoning. Bethesda, MD: National Library of Medicine; [updated 2023 Apr 1]. https://medlineplus.gov/ency/article/002487.htm
48. Medical management guidelines for sodium hydroxide (NaOH). Agency for Toxic Sub­stances and Disease Registry, reviewed Oct. 21, 2014. https://wwwn.cdc.gov/TSP/MMG/MMGDetails.aspx?mmgid=246&toxid=45
49. Brothwell SL, Fitzsimons PE, Gerrard A, et al. Glycerol intoxication syndrome in young children, following the consumption of slush ice drinks. Arch Dis Child. 2025 Mar 11:arch­dischild-2024-328109.
50. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016677s185,016682s124,018016s071lbl.pdf
51. Sandle T. Bacterial endotoxin risks to pharmaceutical water systems: three cases [sic] stud­ies. ResearchGate, Mar. 2019. https://www.researchgate.net/publication/331481003_Bacterial_endotoxin_risks_to_pharmaceutical_water_systems_Three_cases_studies
52. Marek E, Kraft WK. Ethanol pharmacokinetics in neonates and infants. Curr Ther Res Clin Exp. 2014 Oct 22;76:90-97.
53. Sun F, Jaspers TC, van Hasselt PM, et al. A mixed micelle formulation for oral delivery of vitamin K. Pharm Res. 2016 Sep;33(9):2168-2179.
54. Doles W, Wilkerson G, Morrison S, et al. Glacial acetic acid adverse events: case reports and review of the literature. Hosp Pharm. 2015 Apr;50(4):304-309.
55. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012223s042lbl.pdf

This article appeared in Wise Traditions in Food, Farming and the Healing Arts, the quarterly journal of the Weston A. Price Foundation, Summer 2025

🖨️ Print post